sounds like eyedrops
seems cheap, they would be working on getting a 30% return on investment
the big advantage ELX. have is its existing distribution and marketing channels. By slotting another product in you are simply leveraging off the existing infrastructure. A smaller player has to give away a lot of margin to distribute/market
thats how I see it. 2014 should be a great year for ELX, esp if the Aussie hits 80c, it will dramatically boost the bottom line
ellex acquisition company inc, page-11
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
-0.005(1.89%) |
Mkt cap ! $60.63M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 26.0¢ | $43.73K | 167.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 242306 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 29509 | 3 |
View Market Depth
| Last trade - 10.31am 10/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |